Limited capacity in US pediatric drug trials: qualitative analysis of expert interviews
{{output}}
Background: The recently renewed Best Pharmaceuticals for Children and Pediatric Research Equity Acts (BPCA/PREA) have continued industry incentives and opportunities for pediatric drug trials (PDTs). However, there is no current... ...
